IFNG and neoplasm: Our findings demonstrated a significant gradient distribution of the score across different immune subtypes: C2 (IFN-γ dominant subtype) and C3 (inflammatory subtype) exhibited the lowest scores and the most favorable prognosis, indicative of a robust anti-tumor immune microenvironment.